Clinical Trials

Mammogram tech and patient, NAPBC accreditation logo

Englewood Hospital’s physician-investigators are currently recruiting research subjects for participation in the following breast oncology clinical trials.

A011801: The COMPASSHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): COMPASSHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared with T-DM1 and Tucatinib

Principal Investigator: Jill Morrison, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 04457596
Englewood Health IRB #: E-21-850
More Information (

MarginProbe 2.0 Data Collection Protocol

Principal Investigator: Jenna Gillen, DO
Coordinator: William Dippolito
Phone: 201-608-2572
NCT #: 05377229
Englewood Health IRB #: E-24-960
More Information (

Share This